Advertisement

Neuroprotective effects of riluzole in Huntington’s disease

  • Ferdinando Squitieri
  • Andrea Ciammola
  • Claudio Colonnese
  • Andrea Ciarmiello
Letter to the editor

Keywords

Poly Glutamine Riluzole Serum BDNF Serum BDNF Level Untreated Subject 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgements

We thank all patients and their families (Associazione Italiana Corea di Huntington-Neuromed). The financial support of Telethon-Italy to FS (Grant No. GGP06181), is gratefully acknowledged.

References

  1. 1.
    Bergerot A, Shortland PJ, Anand P, et al. Co-treatment with riluzole and GDNF is necessary for functional recovery after ventral root avulsion injury. Exp Neurol 2004;187:359–66.PubMedCrossRefGoogle Scholar
  2. 2.
    Katoh-Semba R, Asano T, Ueda H, et al. Riluzole enhances expression of brain-derived neurotrophic factor with consequent proliferation of granule precursor cells in the rat hippocampus. FASEB J 2002;16:1328–30.PubMedGoogle Scholar
  3. 3.
    Gauthier LR, Charrin BC, Borrell-Pages M, et al. Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules. Cell 2004;118:127–38.PubMedCrossRefGoogle Scholar
  4. 4.
    Ciammola A, Sassone J, Cannella M, et al. Low brain-derived neurotrophic factor (BDNF) levels in serum of Huntington’s disease patients. Am J Med Genet B Neuropsychiatr Genet 2007;144B:574–7.CrossRefGoogle Scholar
  5. 5.
    Ciarmiello A, Cannella M, Lastoria S, et al. Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington’s disease. J Nucl Med 2006;47:215–22.PubMedGoogle Scholar
  6. 6.
    Alfano B, Brunetti A, Covelli EM, et al. Unsupervised, automated segmentation of the normal brain using a multispectral relaxometric magnetic resonance approach. Magn Reson Med 1997;37:84–93.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • Ferdinando Squitieri
    • 1
    • 4
  • Andrea Ciammola
    • 2
  • Claudio Colonnese
    • 1
  • Andrea Ciarmiello
    • 3
  1. 1.IRCCS NeuromedPozzilliItaly
  2. 2.Department of Neurology and Laboratory of Neuroscience, “Dino Ferrari” CenterIRCCS Istituto Auxologico ItalianoMilanItaly
  3. 3.Nuclear Medicine UnitIRCCS PascaleNaplesItaly
  4. 4.Neurogenetics Unit, IRCCS NeuromedCentre for Rare DiseasesPozzilliItaly

Personalised recommendations